Pure Global
PACTR202006915898923

Treatment of primary palmar hyperhidrosis

Efficacy, safety and quality of life of oxybutynin versus aluminum chloride hexahydrate in treating primary palmar hyperhidrosis
Mansoura university faculty of medicine·Not Applicable·Pan Africa Clinical Trials Registry·drugRecruitment Completed
Study focus
Disease/Condition
Skin and Connective Tissue Diseases
Intervention type
drug
Sponsor & location
Primary sponsor
Mansoura university faculty of medicine
Funder
Heba Shawky Attallah Elsayed
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
May 25, 2016
End date
Nov 15, 2020
Summary

Palmar hyperhidrosis is characterized by excessive sweating beyond the physiological needs of the patient's body and the most frequent form is primary or essential. Different treatments protocols have been proposed to control or decrease sweating. This study aimed to compare the efficacy and safety of oral oxybutynin versus topical aluminum chloride hexahydrate (ACH) in treating primary palmar hyperhidrosis. Also, to assess quality of life (QOL) as a measure of improvement in hyperhidrosis state.

ICD-10 classifications
Systemic disorders of connective tissue in diseases classified elsewhereSystemic disorders of connective tissue in other diseases classified elsewhereDiseases of the skin and subcutaneous tissueOther disorders of skin and subcutaneous tissue in diseases classified elsewhereOther disorders of the skin and subcutaneous tissue
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202006915898923
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202006915898923 through Pure Global AI's free database. This Not Applicable trial is sponsored by Mansoura university faculty of medicine and is currently Recruitment Completed. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.